Cutler Group LP Axsome Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 200 shares of AXSM stock, worth $19,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 600 66.67%

Holding current value

$19,406

Previous $47,000 68.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$69.39 - $97.64 $27,756 - $39,056	-400 Reduced 66.67%	200 $15,000
Q4 2023 Jan 18, 2024	SELL	$57.42 - $83.61 $11,484 - $16,722	-200 Reduced 25.0%	600 $47,000
Q3 2023 Nov 07, 2023	BUY	$69.25 - $82.21 $55,400 - $65,768	800 New	800 $55,000
Q1 2023 May 01, 2023	SELL	$58.39 - $75.0 $185,096 - $237,750	-3,170 Reduced 59.52%	2,156 $132,000
Q4 2022 Feb 07, 2023	SELL	$39.94 - $79.72 $281,137 - $561,149	-7,039 Reduced 56.93%	5,326 $410,000
Q3 2022 Oct 25, 2022	BUY	$36.06 - $69.85 $324,359 - $628,300	8,995 Added 266.91%	12,365 $551,000
Q2 2022 Aug 04, 2022	SELL	$21.74 - $46.75 $96,743 - $208,037	-4,450 Reduced 56.91%	3,370 $129,000
Q1 2022 Apr 14, 2022	SELL	$23.7 - $41.39 $298,857 - $521,927	-12,610 Reduced 61.72%	7,820 $323,000
Q4 2021 Jan 18, 2022	BUY	$30.7 - $43.36 $94,433 - $133,375	3,076 Added 17.73%	20,430 $771,000
Q3 2021 Oct 26, 2021	BUY	$19.91 - $68.26 $254,927 - $874,001	12,804 Added 281.41%	17,354 $571,000
Q2 2021 Jul 19, 2021	BUY	$50.63 - $73.5 $39,238 - $56,962	775 Added 20.53%	4,550 $306,000
Q1 2021 Apr 26, 2021	SELL	$55.91 - $81.44 $162,809 - $237,153	-2,912 Reduced 43.55%	3,775 $213,000
Q4 2020 Jan 21, 2021	BUY	$66.31 - $86.52 $343,949 - $448,779	5,187 Added 345.8%	6,687 $544,000
Q3 2020 Oct 27, 2020	SELL	$68.34 - $85.84 $148,297 - $186,272	-2,170 Reduced 59.13%	1,500 $106,000
Q2 2020 Jul 22, 2020	BUY	$49.87 - $98.69 $63,334 - $125,336	1,270 Added 52.92%	3,670 $301,000
Q1 2020 May 07, 2020	SELL	$41.2 - $101.31 $43,260 - $106,375	-1,050 Reduced 30.43%	2,400 $141,000
Q4 2019 Feb 06, 2020	SELL	$16.71 - $106.24 $118,975 - $756,428	-7,120 Reduced 67.36%	3,450 $356,000
Q3 2019 Oct 28, 2019	BUY	$20.24 - $29.16 $51,004 - $73,483	2,520 Added 31.3%	10,570 $213,000
Q2 2019 Aug 09, 2019	SELL	$13.46 - $25.75 $70,665 - $135,187	-5,250 Reduced 39.47%	8,050 $207,000
Q1 2019 May 10, 2019	BUY	$2.63 - $16.34 $34,979 - $217,322	13,300 New	13,300 $189,000

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.16B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account